ANXA5 and B-cell chronic lymphocytic leukemia: Annexin V-FITC/PI analysis showed that BDA-366 is significantly more toxic against CLL (LD50 = 1.11 ± 0.46 μM) than normal PBMCs (LD50 = 2.03 ± 0.31 μM, P < 0.001).